The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1012-1016

  Sarbia, M ^a   Bittinger, F ^b   Porschen, R ^c   Dutkowski, P ^b   Torzewski, M ^a   Willers, R ^a   Gabbert, H E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

MIB 1; Oesophageal cancer

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 0029786089     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.482     Document Type: Article

References (32)

1. AL-SHENEBER IF, SHIBATA HR, SAMPALIS J AND JOTHY S. (1993). Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer, 71, 1954-1959.
2. BAAK JPA. (1990). Mitosis counting in tumors. Hum. Pathol., 21, 683-685.
3. BOUZUBAR N, WALKER KJ, GRIFFITH K, ELLIS IO, ELSTON CW, ROBERTSON JF, BLAMEY RW AND NICHOLSAN RJ. (1989). Ki-67 immunostaining in primary breast cancer: pathological and clinical associations. Br. J. Cancer, 59, 943-947.
4. BROWN DC AND GATTER KC. (1990). Invited review-monoclonal antibody Ki-67: its use in histopathology. Histopathology, 17, 489-503.
5. CATTORETTI G, BECKER MHG, KEY G, DUCHROW M, SCHLÜTER C, GALLE J AND GERDES J. (1992). Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363.
6. CLAYTON F. (1991). Pathologic correlates of survival in 378 lymph node negative infiltrating ductal breast carcinomas: mitotic count is the best single predictor. Cancer, 68, 1309-1317.
7. DEL VECCHIO MT, LEONCINI L, BUERKI K, KRAFT R, MEGHA T, BARBINI P, TOSI P AND COTTIER H. (1991). Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int. J. Cancer, 47, 38-43.
8. GASPARINI G, BEVILACQUA P, POZZA F, MELI S, BORACCHI P, MARUBINI E AND SAINSBURY JR. (1992). Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer. Br. J. Cancer, 66, 970-976.
9. GERDES J, LEMKE H, BAISCH H, WACKER HH, SCHWAB U AND STEIN H. (1984). Cell cycle analysis of a proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715.
10. HALL PA, RICHARDS MA, GREGORY WM, D'ARDENNE AJ, LISTER TA AND STANSFELD AG. (1988). The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J. Pathol., 154, 223-235.
11. HIPELAINEN M, ESKELINEN M, LIPPONEN P, CHANG F AND SYRJÄNEN K. (1993). Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Res., 13, 677-682.
12. HSU SM, RAINE L AND FANGER H. (1981). Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochemistry, 29, 577-580.
13. INTERNATIONAL UNION AGAINST CANCER. (1992). TNM Classification of Malignant Tumours, 4th edn. Springer: Berlin.
14. JIZUKA T, ISONO K, KAKEGAWA T AND WATANABE H. (1993). Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest, 96, 1005-1011.
15. KAMEL OW, FRANKLIN WA, RINGUS JC AND MEYER JS. (1989). Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am. J. Pathol., 134, 107-113.
16. KATO H, TACHIMORI Y, WATANABE H AND JIZUKA T. (1993). Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int. J. Cancer, 53, 220-223.
17. KUBOTA Y, PETRAS RE, EASLKY KA, BAUER TW, TUBBS RR AND FAZIO VW. (1992). Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer, 70, 2602-2609.
18. MAYER A, TAKIMOTO M, FRITZ E, SCHELLANDER G, KOFLER K AND LUDWIG H. (1993). The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer, 73, 2454-2460.
19. PORSCHEN R, KRIEGEL A, LANGEN C, CLASSEN S, HILSE M, LOHE B. HENGELS KJ AND BORCHARD F. (1991). Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki-67 immunostaining. Int. J. Cancer, 47, 686-691.
20. QUINN CM AND WRIGHT NA. (1990). The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J. Pathol., 160, 93-102.
21. RAILO M, NORDLING S, VON BOGUSLAWSKY K, LEIVONEN M, KYLLONEN L AND VON SMITTEN K. (1993). Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br. J. Cancer, 68, 579-583.
22. SIMONY J, PUJOL JL, RADAL M, URSULE E, MICHEL FB AND PUJOL H. (1990). In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Res., 50, 4382-4387.
23. SIMPSON JF AND PAGE DL. (1994). Cellular proliferation and prognosis in breast cancer: statistical purity versus clinical utility (editorial). Hum. Pathol., 25, 331-332.
24. STAUNTON MJ AND GAFFNEY EF. (1995). Tumor type is a determinant of susceptibility to apoptosis. Am. J. Clin Pathol., 103, 300-307.
25. STEEL GG. (1967). Cell loss as a factor in the growth rate of human tumors. Eur. J. Cancer, 3, 381-387.
26. TANNOCK IF. (1987). Tumor growth and cell kinetics. In The Basic Science of Oncology, Tannock IF, Hill RP (eds). Pergamon Press: Oxford.
27. TROJANI M, CONTESSO G, COINDRE JM, ROUESSE J, BUI NB, DE MASCAREL A, GOUSSOT JF, DAVID M, BONICHON F AND LAGARDE C. (1984). Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int. J. Cancer, 33, 37-42.
28. WALKER RA AND CAMPLEJOHN RS. (1988). Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br. J. Cancer, 57, 281-283.
29. WEIDNER N, MOORE DH AND VARTANIAN R. (1994). Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel 'paraffin'-reactive MIBI antibody. Hum. Pathol., 25, 337-342.
30. WORLD HEALTH ORGANIZATION. (1990). Histological Typing of Oesphageal and Gastric Tumours, 2nd edn. Springer: Berlin.
31. YONEMURA Y, OOYAMA S, SUGIYAMA K, NINOMIYA I, KAMATA T, YAMAGUCHI A, MATSUMOTO H AND MIYAZAKI I. (1990). Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer, 65, 1130-1134.
32. YOUSSEF EM, MATSUDA T, TAKADA N, OSUGI H, HIGASHINO M, KINOSHITA H, WATANABE T, KATSURA Y, WANIBUCHI H AND FUKUSHIMA S. (1995). Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer, 76, 358-366.